India's Rise as a Vaccine Superpower: A Closer Look

India, now a leading vaccine producer, manufactures 60% of the world's vaccines. This achievement was highlighted by Prof Balram Bhargava during a keynote at RGCB, emphasizing the seamless integration of government-supported vaccine development. Dr Sharmila Bapat and Prof Chandrabhas Narayana celebrated women's contributions to scientific research.

India has emerged as a leading global vaccine producer, manufacturing 60% of the world's vaccines, according to Prof Balram Bhargava, former Director General of the Indian Council of Medical Research (ICMR). Speaking at the BRIC-RGCB Women's Day event, Bhargava highlighted the country's pioneering efforts in vaccine development and exportation.

In his keynote address, Prof Bhargava emphasized the seamless implementation of vaccine development processes, supported by government initiatives and a dedicated National Task Force. During the Omicron wave, India's vaccination drive contributed to one of the lowest global death rates, showcasing effective crisis management.

Dr Sharmila Bapat, a notable figure in cancer stem cell research, urged women to pursue scientific research, noting the existing support schemes. Prof Chandrabhas Narayana of RGCB underscored the critical role of women in research programs and international collaborations.